Abstract

Mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) and MKP-2 are two members of a recently described family of dual specificity phosphatases that are capable of dephosphorylating p42/p44MAPK. Overexpression of MKP-1 or MKP-2 inhibits MAP kinase-dependent intracellular signaling events and fibroblast proliferation. By using specific antibodies that recognize endogenous MKP-1 and MKP-2 in CCL39 cells, we show that MKP-1 and MKP-2 are not expressed in quiescent cells, but are rapidly induced following serum addition, with protein detectable as early as 30 min (MKP-1) or 60 min (MKP-2). Serum induction of MKP-1 and MKP-2 is sustained, with protein detectable up to 14 h after serum addition. Induction of MKP-1 and, to a lesser extent, MKP-2 temporally correlates with p42/p44MAPK inactivation. To analyze the contribution of the MAP kinase cascade to MKP-1 and MKP-2 induction, we examined CCL39 cells transformed with either v-ras or a constitutively active direct upstream activator of MAP kinase, mitogen-activated protein kinase kinase-1 (MKK-1; MKK-1(SD/SD) mutant). In both cell models, MKP-1 and MKP-2 are constitutively expressed, with MKP-2 being prevalent. In addition, in CCL39 cells expressing an estradiol-inducible deltaRaf-1::ER chimera, activation of Raf alone is sufficient to induce MKP-1 and MKP-2. The role of the MAP kinase cascade in MKP induction was highlighted by the MKK-1 inhibitor PD 098059, which blunted both the activation of p42/p44MAPK and the induction of MKP-1 and MKP-2. However, the MAP kinase cascade is not absolutely required for the induction of MKP-1, as this phosphatase, but not MKP-2, was induced to detectable levels by agents that stimulate protein kinases A and C. Thus, activation of the p42/p44MAPK cascade promotes the induction of MKP-1 and MKP-2, which may then attenuate p42/p44MAPK-dependent events in an inhibitory feedback loop.

Highlights

  • To analyze the contribution of the Mitogen-activated protein (MAP) kinase cascade to MAP1 kinase phosphatases (MKPs)-1 and MKP-2 induction, we examined CCL39 cells transformed with either v-ras or a constitutively active direct upstream activator of MAP kinase, mitogen-activated protein kinase kinase-1 (MKK-1; MKK-1(SD/SD) mutant)

  • To analyze the contribution of the MAP kinase cascade to MKP-1 and MKP-2 induction, we examined CCL39 cells transformed with either v-ras or a constitutively active direct upstream activator of MAP kinase, mitogen-activated protein kinase kinase-1 (MKK-1; MKK-1(SD/SD) mutant)

  • A more detailed analysis revealed that the two mRNA species that were identified with MKP-1 and MKP-2 probes were induced by serum with a time course similar to that previously noted for MKP-1 and MKP-2

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials [␥-32P]ATP and the enhanced chemiluminescence (ECL) immunodetection system were obtained from Amersham Corp.; antiserum E1B, which recognizes p42 and p44MAPK on Western blots, and antiserum Kelly, which immunoprecipitates p42/p44MAPK activity, were as previously detailed [38]. Antisera immunoprecipitating p44MAPK were a kind gift of Dr Sylvain Meloche [39]. Anti-cyclin D1 antisera were a kind gift of Dr Veronique Baldin. The GST-Jun-(1–79) and GST-ATF-2-(1–149) expression vectors were kind gifts of Dr M. The Flag-p46JNK expression vector was a kind gift of Dr B. The specific p38MAPK inhibitor SB 203580 was supplied by SmithKline Beecham. The specific MKK-1/2 inhibitor PD 098059 was purchased from New England Biolabs Inc. Bovine myelin basic protein and bovine serum albumin were purchased from Sigma. Triton X-100 and Nonidet P-40 were from Pierce

Cells and Culture Conditions
Northern Blot Analysis
Western Blot Analysis
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call